Clinical Trials: Phase I/II Trial of Dasatinib (Sprycel) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma

Sponsor and Collaborators

M.D. Anderson Cancer Center

Bristol-Myers Squibb

Contact

John De Groot, MD, 713-792-2883

Principal Investigator

John De Groot, MD UT MD Anderson Cancer Center

ClinicalTrials.gov Identifier